AstraZeneca

The first batch of Covid-19 vaccines that were granted emergency approvals in 2020 and rolled out for immunisation in 2021 have not worked very well in providing long-term protection against newer variants and the world is waiting for…

Drug firm AstraZeneca India on Friday said it has received an approval from the Drugs Controller General of India to market its drug for the treatment of breast cancer. The Drugs Controller General of India (DCGI) has approved Lynparza…

French healthcare company Sanofi said it would stop further work on amcenestrant, once seen to have large potential against breast cancer, after a second trial failure dealt a major blow to its drug development prospects. The move puts…

Serum Institute of India (SII) is reportedly working on an Omicron-specific vaccine, according to a report of . SII Chief Executive Officer Adar Poonawalla told NDTV that the vaccine is being developed in collaboration with Novavax.…

Several pharma companies have expressed their concerns over the government's move to implement trade margin rationalisation (TMR) on innovative or patented drugs that these companies provide to patients for little or no cost. Many…

NEW DELHI: India said on Wednesday that Biological E's Covid-19 vaccine Corbevax can be administered as a booster dose in people who have taken the country's other two main shots, Covaxin and AstraZeneca's Covishield, from Friday.…

As Boris Johnson on Thursday announced that his innings at 10 Downing Street will soon end, his term as British Prime Minister will be remembered for setting the India-UK relations on the course of a "Comprehensive Strategic…

A new study published in the Lancet has revealed that AstraZeneca's Covid-19 vaccine, which is being used in India as Covishield, is well tolerated and immunogenic in children aged 6-17 years. "No safety concerns were raised in this…